2020 ACC专家共识决策路径:经导管主动脉瓣置换术后传导障碍的管理
该文件由美国心脏病学会Solution Set监督委员会发布,针对经导管主动脉瓣置换术(TAVR)后传导障碍缺乏高质量随机试验证据的现状,回顾现有数据与经验,提出基于证据的专家共识决策路径;证据不足处建议基于专家意见。
要点
- TAVR术后传导障碍常为一过性,管理策略需结合证据与专家意见。
- 现有实践包括延长观察、电生理检查及预防性起搏器植入。
- 文件为美国首份系统汇总TAVR术后传导障碍管理策略的学会文件。
核心结论
- 针对TAVR术后传导障碍,在缺乏充分把握度随机对照试验的情况下,本文件提出基于证据的专家共识决策路径,证据不足处依据专家意见。
研究设计与样本
- 美国心脏病学会Solution Set监督委员会发布的专家共识决策路径文件,回顾现有数据与经验,未报告系统检索范围与样本量。
主要发现
- TAVR术后传导障碍常呈一过性,相关技术不断演变,且涉及多个心脏病学亚专科的协作。
- 因缺乏高质量试验,实践中已形成多种处理风格,包括延长观察、电生理检查和预防性起搏器植入。
临床怎么用
- 文件提出TAVR术后传导障碍管理的专家共识决策路径,供临床参考;证据缺乏或不足时的推荐基于专家意见。
局限性
- 缺乏足够把握度的随机对照试验;传导障碍常为一过性;技术持续演变;涉及多亚专科协作的复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Consensus regarding a reasonable strategy to manage cardiac conduction disturbances after transcatheter aortic valve replacement (TAVR) has been elusive. This is due to the absence of adequately powered, randomized controlled trials; the often transient nature of the conduction disturbances; evolving technologies; and the interplay of cardiology subspecialties involved. In the absence of high-quality trials, numerous practice styles have been developed, and prolonged observation, electrophysiological testing, and pre-emptive pacemaker implantation have been described. Although the 2013 European Society of Cardiology guidelines address pacing post-TAVR, they do not provide in-depth discussion of this topic. Furthermore, a summary and proposed strategy for this problem have not been published by cardiovascular societies in the United States, despite an interest in establishing best practices in TAVR, valvular heart disease, and cardiovascular implantable electrical devices. This document reviews existing data and experience regarding the management of conduction disturbances after TAVR and proposes an evidence-based expert consensus decision pathway for their management. Where evidence is lacking or insufficient, the recommendations herein are based on expert opinion.
引用
- Lilly SM, Deshmukh AJ, Epstein AE, et al. 2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020. PMID: 33190683. doi:10.1016/j.jacc.2020.08.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。